Drug-related hyperprolactinemia.
D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects*; D005260:Female; D005444:Flunarizine / Q000009:adverse effects; D005473:Fluoxetine / Q000009:adverse effects; D016666:Fluvoxamine / Q000009:adverse effects; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D007217:Indoramin / Q000009:adverse effects; D017374:Paroxetine / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D013469:Sulpiride / Q000009:adverse effects / Q000031:analogs & derivatives*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D005444:Flunarizine; D005473:Fluoxetine; D016666:Fluvoxamine; D007217:Indoramin; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors; D013469:Sulpiride